Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-C Lega

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Arthritis Research & Therapy|April 5, 2019
Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literatureM R Pokeerbux, J Giovannelli, L Dauchet, et al.
QJM : Monthly Journal of the Association of Physicians|October 9, 2019
Acute renal and splenic infarctions: a reviewE Weber, F Grangeon, Q Reynaud, et al.
European Journal of Internal Medicine|October 30, 2021
Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitisC Mettler, C A Durel, P Guilpain, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Arthritis Research & Therapy|April 5, 2019
Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literatureM R Pokeerbux, J Giovannelli, L Dauchet, et al.
QJM : Monthly Journal of the Association of Physicians|October 9, 2019
Acute renal and splenic infarctions: a reviewE Weber, F Grangeon, Q Reynaud, et al.
European Journal of Internal Medicine|October 30, 2021
Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitisC Mettler, C A Durel, P Guilpain, et al.
Pageof 4